Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

A group of scientists looking into regenerative dentistry has managed what had previously been deemed impossible.

Chugai Pharma seeks Japanese additional indication approval for Tecentriq to treat thymic carcinoma: Tokyo Thursday, May 15, 2025, 12:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd., ...

Rein Therapeutics has initiated the randomised RENEW Phase II trial of its Caveolin-1-related peptide, LTI-03, targeting ...

Rein Therapeutics has begun screening and recruiting patients for its renew phase 2 trial, assessing LTI-03 as a potential ...

Recently published randomized controlled trial involved 132 patients undergoing wide local excision of unilateral tongue ...

An AI-driven model trained on digital pathology slides accurately classified pediatric sarcoma subtypes in a multicenter ...

The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026 In the previously reported Phase 1b study, LTI-03 showed ...

Rein Therapeutics initiates RENEW phase 2 trial of LTI-03 in patients with idiopathic pulmonary fibrosis: Austin, Texas Tuesday, May 13, 2025, 18:00 Hrs [IST] Rein Therapeutics (R ...

Background: Krebs von den Lungen-6 (KL-6), predominantly expressed by type II alveolar cells, is linked to the prognosis and severity of interstitial lung disease (ILD). This investigation sought to ...

A recent microbiological study 4 used RiboFree to explore how Mycobacterium tuberculosis (M.tb), the bacterium that causes tuberculosis (TB), responds when exposed to alveolar lining fluid (ALF ...

Conclusion: This study provides evidence that smoking enhances PAD2 expression in the bronchial mucosal and alveolar compartment, with consequent generation of citrullinated proteins in the latter.